Top Markets
#1 Islamic Coin Islamic Coin +154.34%
#2 PulseChain PulseChain +51.99%
#3 BOOK OF MEME BOOK OF MEME +43.75%
#4 DogBull DogBull +34.41%
#5 ORDI ORDI +19.01%
#6 Ergo Ergo +18.18%
#7 Nockchain Nockchain +17.41%
#8 rsERG rsERG +16.56%
#9 RedStone RedStone +15.97%
#10 Victoria VR Victoria VR +15.41%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Clasificación en acciones #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Precio por acción
$1.48
Última sincronización: 2023-05-31
Capitalización bursátil
$35.54M
Cambio (1 día)
-5.73%
Cambio (1 año)
0.00%
País
US
Comercio TCR2 Therapeutics Inc. (TCRR)

Categoría

Healthcare
Historial del precio de la acción de TCR2 Therapeutics Inc. (TCRR)
Precio más alto de cierre: $1.83 el 2023-05-01

Precio más bajo de cierre: $16.51 el 2019-02-01
Historial del precio de la acción de TCR2 Therapeutics Inc. desde 2019 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 73.43%
2022 -78.52%
2021 -83.60%
2020 79.84%
2019 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $756.93 6.35%
CH